Research Papers

25 of 2004 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer.
Yang J; Zhang Y; Cheng S; Xu Y; Wu M; Gu S; Xu S; Wu Y; Wang C; Wang Y.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Robust machine-learning based prognostic index using cytotoxic T lymphocyte evasion genes highlights potential therapeu…
Wang X; Chan S; Chen J; Xu Y; Dai L; Han Q; Wang Z; Zuo X; Yang Y; Zhao H; Wang M; Wang C; Li Z; Zhang H; Chen W.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
EN1 promotes lung metastasis of salivary adenoid cystic carcinoma by regulating the PI3K-AKT pathway and epithelial-mes…
Cui Y; Zhang Y; Liu Y; Zhou Z; Zhu L; Zhou CX.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894.
Zhou X; Chang L; Liang Q; Zhao R; Xiao Y; Xu Z; Yu L.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcino…
Park JS; Lee ME; Kim J; Oh K; Lee N; Jung M; Jang WS; Ham WS.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Elucidating the role of Pyroptosis in papillary thyroid cancer: prognostic, immunological, and therapeutic perspectives.
Li F; Du R; Kou J; Li J; Zhou L; Zhang D; Fu Y; Dionigi G; Bertoli S; Sun H; Liang N.
Cancer Cell Int (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Fabrication of magnetic niosomal platform for delivery of resveratrol: potential anticancer activity against human panc…
Firouzi Amandi A; Bahmanyar Z; Dadashpour M; Lak M; Natami M; Döğüş Y; Alem M; Adeli OA.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids.
Wang H; Zhang Y; Miao H; Xu T; Nie X; Cheng W.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
B cells in head and neck squamous cell carcinoma: current opinion and novel therapy.
Guo X; Xu L; Nie L; Zhang C; Liu Y; Zhao R; Cao J; Tian L; Liu M.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Stress granules affect the dual PI3K/mTOR inhibitor response by regulating the mitochondrial unfolded protein response.
Lin N; Sun L; Chai J; Qi H; Zhao Y; Ma J; Xia M; Hu X.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma.
Kim D; Park J; Park HC; Zhang S; Park M; Park SA; Lee SH; Lee YS; Park JS; Jeun SS; Chung YJ; Ahn S.
Cancer Cell Int (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma.
Zhang J; Zhou X; Yao F; Zhang J; Li Q.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance.
Qi J; Liu S; Zhang Z.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker…
Xu L; Chen S; Li Q; Chen X; Xu Y; Zhou Y; Li J; Guo Z; Xing J; Chen D.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Navigating challenges: optimising methods for primary cell culture isolation.
Piwocka O; Musielak M; Ampuła K; Piotrowski I; Adamczyk B; Fundowicz M; Suchorska WM; Malicki J.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
DNA mismatch repair system regulates the expression of PD-L1 through DNMTs in cervical cancer.
Guo F; Lu R; Kong W; Anwar M; Feng Y.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated an…
Kang J; Jiang J; Xiang X; Zhang Y; Tang J; Li L.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular car…
Tang J; Peng X; Xiao D; Liu S; Tao Y; Shu L.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Interplay of miRNAs and lncRNAs in STAT3 signaling pathway in colorectal cancer progression.
Rahbar Farzam O; Najafi S; Amini M; Rahimi Z; Dabbaghipour R; Zohdi O; Asemani Shahgoli G; Baradaran B; Akbari B.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical applications and perspectives of circulating tumor DNA in gastric cancer.
Li JH; Zhang DY; Zhu JM; Dong L.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells.
Wang K; Lu Y; Li H; Zhang J; Ju Y; Ouyang M.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
RORα inhibits gastric cancer proliferation through attenuating G6PD and PFKFB3 induced glycolytic activity.
Wang X; Zhang J; Wu Y; Zhang Y; Zhang S; Li A; Wang J; Wang Z.
Cancer Cell Int (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to res…
Soumoy L; Genbauffe A; Mouchart L; Sperone A; Trelcat A; Mukeba-Harchies L; Wells M; Blankert B; Najem A; Ghanem G; Saussez S; Journe F.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and …
Wang M; Guo H; Zhang B; Shang Y; Zhang S; Liu X; Cao P; Fan Y; Tan K.
Cancer Cell Int (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Abnormal arginine synthesis confers worse prognosis in patients with middle third gastric cancer.
Hong L; Tang X; Han J; Wang J; Xu Q; Zhu X.
Cancer Cell Int (Unknown)
Published: 2024
3/6 Transparent
Funding Declared